Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Hospital Practice (1995)|December 16, 2014
Hospital-acquired thrombocytopeniaChristine M McMahon, Adam CukerLeukemia & Lymphoma|September 21, 2018
Management of primary refractory acute myeloid leukemia in the era of targeted therapiesChristine M McMahon, Alexander E PerlSeminars in Hematology|March 31, 2019
Maintenance therapy in acute myeloid leukemia: What is the future?Christine M McMahon, Selina M LugerCurrent Hematologic Malignancy Reports|March 19, 2019
Relapsed T Cell ALL: Current Approaches and New DirectionsChristine M McMahon, Selina M LugerExpert Review of Clinical Pharmacology|August 28, 2019
Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemiaChristine M McMahon, Alexander E PerlCancer Research|May 13, 2010
Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor statusJulie Hanson Ostrander, Christine M McMahon, Siya Lem, et al.Journal of the American Academy of Dermatology|November 7, 2017
Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral centerCaroline A Nelson, Megan H Noe, Christine M McMahon, et al.Leukemia|August 17, 2023
Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxisNatalia J Gurule, Kenneth C Malcolm, Chelsea Harris, et al.JCO Clinical Cancer Informatics|October 4, 2022
Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/AzacitidineNazmul Islam, Jamie S Reuben, Justin Dale, et al.Cancer Discovery|May 16, 2019
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid LeukemiaChristine M McMahon, Timothy Ferng, Jonathan Canaani, et al.Pageof 2